Spero Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Spero Therapeutics (SPRO) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Spero Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Spero Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Spero Therapeutics by UBS Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $483 | 329 | 1.47 |
2023-09-30 | $33k | 27k | 1.20 |
2023-06-30 | $39k | 27k | 1.45 |
2023-03-31 | $60k | 42k | 1.45 |
2022-12-31 | $79k | 46k | 1.73 |
2022-09-30 | $46k | 23k | 2.00 |
2022-06-30 | $999 | 755 | 1.32 |
2022-03-31 | $7.0k | 755 | 9.27 |
2021-12-31 | $520k | 33k | 15.71 |
2021-09-30 | $530k | 29k | 18.39 |
2021-06-30 | $27k | 1.9k | 14.29 |
2021-03-31 | $456k | 31k | 14.71 |
2020-12-31 | $277k | 14k | 19.33 |
2020-09-30 | $6.0k | 500 | 12.00 |
2020-06-30 | $79k | 6.0k | 13.33 |
2020-03-31 | $73k | 9.0k | 8.14 |
2019-12-31 | $137k | 14k | 9.60 |
2019-09-30 | $117k | 11k | 10.59 |
2019-06-30 | $136k | 12k | 11.52 |
2018-12-31 | $20k | 3.2k | 6.25 |
2018-09-30 | $25k | 2.4k | 10.60 |
2018-06-30 | $13k | 945 | 14.20 |
2018-03-31 | $5.0k | 496 | 10.00 |
2017-12-31 | $0 | 128 | 0.00 |